A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar

Journal of Evaluation in Clinical Practice

Volumn 21, Issue 4, 2015, Pages 703-709

  Elewa, Hazem ^a   Alkhiyami, Dania ^a   Alsahan, Dima ^a   Abdel Aziz, Ahmed ^b  

^a Qatar University ^*  (Qatar)

^b HAMAD GENERAL HOSPITAL   (Qatar)

Author keywords

attitude; challenges; clinical application; doctors; pharmacists; pharmacogenomics; Qatar

Indexed keywords

ADULT; ARTICLE; AWARENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DRUG COST; DRUG DOSE; DRUG MONITORING; DRUG THERAPY; FEMALE; HUMAN; MALE; PATIENT EDUCATION; PHARMACIST ATTITUDE; PHARMACOGENOMICS; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QATAR; RESPONSIBILITY; SCORING SYSTEM; ATTITUDE TO HEALTH; PHARMACIST; PHARMACOGENETICS; PHYSICIAN; PSYCHOLOGY; QUESTIONNAIRE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PHARMACISTS; PHARMACOGENETICS; PHYSICIANS; QATAR; SURVEYS AND QUESTIONNAIRES;

EID: 84938209837     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12372     Document Type: Article

References (24)

1. Lander, E. S., Linton, L. M., Birren, B., et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409 (6822), 860-921. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.].
2. Shi, M. M., Bleavins, M. R., &, de la Iglesia, F. A., (2001) Pharmacogenetic application in drug development and clinical trials. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 29 (4 Pt 2), 591-595. [Congresses].
3. Feero, W. G., Guttmacher, A. E., &, Collins, F. S., (2010) Genomic medicine-an updated primer. The New England Journal of Medicine, 362 (21), 2001-2011. [Review].
4. Kleyn, P. W., &, Vesell, E. S., (1998) Genetic variation as a guide to drug development. Science, 281 (5384), 1820-1821.
5. Johnson, J. A., Gong, L., Whirl-Carrillo, M., et al. (2011) Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clinical Pharmacology and Therapeutics, 90 (4), 625-629.
6. Scott, S. A., Sangkuhl, K., Stein, C. M., et al. (2013) Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clinical Pharmacology and Therapeutics, 94 (3), 317-323.
7. Food and Drug Administration (FDA) (2015) Table of pharmacogenomic biomarkers in drug labeling. FDA. Available at: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm (last accessed 23 January 2015).
8. McCullough, K. B., Formea, C. M., Berg, K. D., et al. (2011) Assessment of the pharmacogenomics educational needs of pharmacists. American Journal of Pharmaceutical Education, 75 (3), 51. [Research Support, N.I.H., Extramural].
9. Stanek, E. J., Sanders, C. L., Taber, K. A., et al. (2012) Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clinical Pharmacology and Therapeutics, 91 (3), 450-458.
10. Streetman, D. S., (2007) Emergence and evolution of pharmacogenetics and pharmacogenomics in clinical pharmacy over the past 40 years. The Annals of Pharmacotherapy, 41 (12), 2038-2041.
11. Gurwitz, D., Zika, E., Hopkins, M. M., Gaisser, S., &, Ibarreta, D., (2009) Pharmacogenetics in Europe: barriers and opportunities. Public Health Genomics, 12 (3), 134-141.
12. Tamaoki, M., Gushima, H., &, Tsutani, K., (2007) Awareness survey of parties involved in pharmacogenomics in Japan. Pharmacogenomics, 8 (3), 275-286. [Comparative Study].
13. McMahon, T., &, Tucci, J., (2011) The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications. Pharmacy Practice (Granada), 9 (3), 141-147.
14. Ratanajamit, C., Kaewpibal, P., Setthawacharavanich, S., &, Faroongsarng, D., (2009) Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs. Journal of the Medical Association of Thailand, 92 (11), 1500-1507. [Comparative Study Research Support, Non-U.S. Gov't].
15. Elewa, H. F., DeRemer, C. E., Keller, K., Gujral, J., &, Joshua, T. V., (2014) Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey. Journal of Thrombosis and Thrombolysis, 38 (1), 115-120.
16. Owusu-Obeng, A., Weitzel, K. W., Hatton, R. C., et al. (2014) Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy, epub (ahead of print).
17. Dellit, T. H., Owens, R. C., McGowan, J. E. Jr, et al. (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 44 (2), 159-177.
18. Nutescu, E. A., Drozda, K., Bress, A. P., et al. (2013) Feasibility of implementing a comprehensive warfarin pharmacogenetics service. Pharmacotherapy, 33 (11), 1156-1164.
19. Mills, R., &, Haga, S. B., (2013) Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. Pharmacogenomics, 14 (8), 957-968. [Research Support, N.I.H., Extramural].
20. Williams, M. S., (2014) Genomic medicine implementation: learning by example. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 166C (1), 8-14.
21. Koomer, A., Lourdes, M., Coronel, C., et al (2011) A pilot study highlighting differences in pharmacists' perceptions regarding use of pharmacogenetic information in their profession (in Louisville Metro Area) based on practicing settings. Asian Journal of Pharmaceutical Research and Health Care, 3 (2), 50-61.
22. Kheir, N., Zaidan, M., Younes, H., El Hajj, M., Wilbur, K., &, Jewesson, P. J., (2008) Pharmacy education and practice in 13 Middle Eastern countries. American Journal of Pharmaceutical Education, 72 (6), 133.
23. American Society of Health-System Pharmacists (ASHP) (2014) ASHP statement on the pharmacist's role in clinical pharmacogenomics. Available at: http://www.ashp.org/DocLibrary/Policy/HOD/StPharmacogenomicsPrepress.aspx (last accessed 17 January 2015).
24. Foddy, W., (1994) Constructing Questions for Interviews and Questionnaires Theory and Practice in Social Research, 1st edn. Cambridge: Cambridge University Press.